statements

Bilcare Ltd.

BSE: 526853

Sector: Healthcare

Industry Group: Healthcare Services

Industry: Healthcare Research, Analytics & Technology

92.97+1.8 (+2.00%)

14 Oct, 12:00 AM

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

Bilcare Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	R 2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	R 2025 Mar 31	2026 Mar 31	TTM Jun 30
	R 2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	R 2025 Mar 31	2026 Mar 31	TTM Jun 30
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR
Total Revenue	3,642	3,547	3,062	2,692	2,603	2,633	2,778	2,997	1,827	623	845	982	747	788	734	773
Cost of Operating Revenue	2,220	2,505	2,002	1,617	1,513	1,606	1,932	2,016	1,240	454	638	803	551	557	516	532
Gross Profit	1,422	1,042	1,060	1,075	1,090	1,027	846	981	587	168	207	179	196	231	217	241
Gross Margin	39.0	29.4	34.6	39.9	41.9	39.0	30.5	32.7	32.1	27.0	24.5	18.2	26.2	29.3	29.6	31.2
Total Operating Expenses	3,296	3,309	2,960	2,698	2,560	2,620	3,037	3,206	2,020	617	824	953	744	761	709	715
Operating Profit	345	238	102	-5	43	13	-259	-209	-193	5	21	29	3	27	25	58
Operating Margin	9.5	6.7	3.3	-0.2	1.7	0.5	-9.3	-7.0	-10.6	0.9	2.5	2.9	0.4	3.5	3.4	7.5
Financing Income/(Expense) - Net	-164	-160	-213	-236	-151	-176	-249	-283	-174	-76	-69	-59	-68	-68	-60	-72
Profit before Taxes	188	76	-101	-196	-194	-56	-207	-433	-114	-25	-4	196	-72	-43	-21	6
Income Taxes	48	19	23	-16	-112	24	-8	21	-15	-14	0	146	-13	-15	-4	-1
Profit after Tax	137	40	-113	-216	-85	-85	-201	-455	-104	-21	-13	15	-33	-1	2	20
PAT Margin	3.7	1.1	-3.7	-8.0	-3.3	-3.2	-7.2	-15.2	-5.7	-3.4	-1.5	1.5	-4.4	-0.1	0.2	2.6
EPS - Basic - ex Extraordinary Items	58.00	22.23	-52.47	-76.34	-36.04	-35.90	-85.43	-193.28	-43.97	-8.95	-5.35	6.39	-14.12	-0.33	0.73	8.55
EPS - Diluted - ex Extraordinary Items	58.00	22.23	-52.47	-76.34	-36.04	-35.90	-85.43	-193.28	-43.97	-8.95	-5.35	6.39	-14.12	-0.33	0.73	8.55
EBIT	345	238	102	-5	43	13	-259	-209	-193	5	21	29	3	27	25	58
EBITDA	545	387	425	186	207	190	158	170	45	51	60	67	48	46	44	86
EBITDA Margin	15.0	10.9	13.9	6.9	7.9	7.2	5.7	5.7	2.5	8.2	7.1	6.8	6.4	5.8	6.1	11.2

Balance Sheet

Abridged

Understanding Balance Sheet

Bilcare Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	C 2012 Mar 31	C 2013 Mar 31	2014 Mar 31	R 2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	R 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	R 2023 Mar 31	R 2024 Mar 31	R 2025 Mar 31	2026 Mar 31
	C 2012 Mar 31	C 2013 Mar 31	2014 Mar 31	R 2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	R 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	R 2023 Mar 31	R 2024 Mar 31	R 2025 Mar 31	2026 Mar 31
Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR
Total Current Assets	2,041	1,993	1,924	1,322	907	788	933	882	365	337	421	343	411	343	353
Long-Term Investments	0	0	0	19	19	10	11	9	7	7	7	196	95	111	39
Property Plant & Equipment - Net	1,369	139	-23	2,058	2,173	2,171	1,927	1,682	509	477	453	1,026	437	449	434
Total Non-Current Assets	1,620	490	375	2,485	2,775	2,718	2,546	2,277	746	727	706	1,250	566	581	490
Total Assets	3,779	4,400	4,368	3,808	3,682	3,506	3,479	3,159	1,112	1,064	1,127	1,593	977	924	843
Total Current Liabilities	706	971	866	922	758	745	1,978	2,069	311	313	403	339	350	340	292
Long Term Debt	1,303	1,769	1,882	1,753	1,893	1,801	741	745	559	530	537	516	545	470	460
Total Non-Current Liabilities	1,686	2,050	2,126	2,092	2,152	2,085	1,037	1,096	624	586	563	551	572	495	477
Total Liabilities	2,392	3,021	2,992	3,014	2,910	2,830	3,015	3,165	935	900	966	889	922	834	769
Total Shareholders' Equity	1,335	1,325	1,324	737	713	614	400	-70	108	86	75	531	211	214	197
Minority Interest	52	54	53	57	59	62	63	64	68	78	86	173	-155	-125	-123
Total Equity	1,387	1,379	1,376	794	772	676	463	-6	176	164	161	704	56	90	74
Total Liabilities & Equity	3,779	4,400	4,368	3,808	3,682	3,506	3,479	3,159	1,112	1,064	1,127	1,593	977	924	843

Cash Flow

Abridged

Understanding Cash Flow Statement

Bilcare Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	C 2013 Mar 31	C 2014 Mar 31	C 2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	C 2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	C 2025 Mar 31	2026 Mar 31
	2012 Mar 31	C 2013 Mar 31	C 2014 Mar 31	C 2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	C 2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	C 2025 Mar 31	2026 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	474	230	355	-189	251	13	-108	-109	136	-2	-9	-24	-13	-28	-8
Working Capital - Increase/(Decrease)	-372	4	-37	-117	-70	115	-38	34	-50	4	-17	-42	3	43	69
Net CF from Operating Activities	102	235	318	-305	181	128	-147	-75	86	2	-26	-66	-10	15	61
Capital Expenditures - Net	392	850	373	-241	189	136	214	114	-1,313	3	5	-18	97	-55	7
Net CF from Investing Activities	-392	-974	-355	237	-362	-133	-206	-106	1,306	-4	-6	35	-115	71	-11
Stock - Issuance/(Retirement) - Net	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Debt - LT & ST - Issuance/(Retirement) - Total	262	663	46	124	150	-22	349	178	-1,430	-10	13	60	118	-89	-61
Net Cash Flow from Financing Activities	285	661	48	119	149	21	340	180	-1,426	-7	14	41	118	-89	-61
Free Cash Flow to Equity	-29	48	-8	59	142	-30	-11	-11	-31	-11	-18	12	11	-19	-7
Free Operating CF net dividend	-297	-799	-153	-	-20	-17	-361	-190	-	-4	-31	-	-130	-7	51
Free Operating CF	-297	-799	-153	-	-20	-17	-361	-190	-	-4	-31	-	-130	-7	51

Business Segment Analysis

FY End:

Mar 26

Bilcare Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Pharma Packaging Research solutions (100.0%)₹ 10.83 Cr

Revenue / Sales

Pharma Packaging Research solutions (100.0%)₹ 733.54 Cr

Assets

Pharma Packaging Research solutions (100.0%)₹ 842.82 Cr

Operating Income

Pharma Packaging Research solutions (100.0%)₹ 24.68 Cr

Regional Segment Analysis

FY End:

Mar 26

Bilcare Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

India (64.7%)₹ 474.48 CrOutside India (35.3%)₹ 259.06 Cr

Historical Segment Analysis

Track how Bilcare Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2024 Mar 31	2025 Mar 31	2026 Mar 31
Pharma Packaging Research solutions	120	23	11

Frequently Asked Questions

What is the revenue of Bilcare Ltd.?

The latest trailing twelve month revenue of Bilcare Ltd. is ₹ 773.04 Cr, reflecting a 1-year growth of -0.92% and a 3-year CAGR of -5.49%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Bilcare Ltd.?

The latest trailing twelve month net profit (PAT) of Bilcare Ltd. is ₹ 10.03 Cr, with a 3-year earnings CAGR of -48.48%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Bilcare Ltd.?

The trailing twelve month EBITDA of Bilcare Ltd. is approximately ₹ 26.01 Cr (based on an operating margin of 3.36%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Bilcare Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Bilcare Ltd. is -7.49. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Bilcare Ltd.?

The debt-to-equity ratio of Bilcare Ltd. stands at 3.15. The interest coverage ratio is 0.47x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Bilcare Ltd.?

The estimated book value per share of Bilcare Ltd. is 83.56 (derived from a P/B ratio of 1.11 and market price of ₹ 92.97), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Bilcare Ltd.?

The trailing twelve month operating cash flow of Bilcare Ltd. is ₹ 61.42 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Bilcare Ltd. report consolidated or standalone financials?

Bilcare Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.